News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Abbott Laboratories (ABT) Profit Falls 40% on Acquisition, Recall Costs


10/20/2010 8:25:03 AM

Wall Street Journal -- Abbott Laboratories reported a 40% drop in third-quarter earnings, weighed down by costs associated with layoffs, a baby-formula recall and the withdrawal of a diet drug due to safety concerns.

Read at Wall Street Journal
Read at Market Watch
Read at ProPublica
Read at Bloomberg


comments powered by Disqus
Abbott
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES